Stockscreener 앱 받기
9.13
4.90%
-0.47
시간 외 거래:
9.13
전일 마감가:
$9.60
열려 있는:
$9.6
하루 거래량:
641.85K
Relative Volume:
0.77
시가총액:
$540.68M
수익:
$1.08B
순이익/손실:
$139.50M
주가수익비율:
3.8499
EPS:
2.3715
순현금흐름:
$205.80M
1주 성능:
-3.49%
1개월 성능:
+2.70%
6개월 성능:
-36.15%
1년 성능:
-16.32%
1일 변동 폭
$9.12
$9.65
1주일 범위
$9.12
$9.90
52주 변동 폭
$8.47
$15.55
Embecta Corp Stock (EMBC) Company Profile
명칭
Embecta Corp
전화
(862) 401-0000
주소
1209 ORANGE STREET, WILMINGTON
Compare EMBC vs ISRG, BDX, MDLN, ALC, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EMBC
Embecta Corp
|
9.13 | 568.51M | 1.08B | 139.50M | 205.80M | 2.3715 |
ISRG
Intuitive Surgical Inc
|
451.29 | 165.37B | 10.06B | 2.88B | 2.49B | 7.876 |
BDX
Becton Dickinson Co
|
156.69 | 45.13B | 21.92B | 1.76B | 2.63B | 6.1223 |
MDLN
Medline Inc
|
47.51 | 39.17B | 28.43B | 1.16B | 1.26B | 1.4457 |
ALC
Alcon Inc
|
77.82 | 39.14B | 10.40B | 980.00M | 1.61B | 1.9749 |
RMD
Resmed Inc
|
221.22 | 32.94B | 5.40B | 1.49B | 1.78B | 10.12 |
Embecta Corp Stock (EMBC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-10 | 개시 | Mizuho | Neutral |
| 2024-12-02 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-27 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2023-10-20 | 개시 | Wolfe Research | Peer Perform |
| 2023-01-06 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2022-09-08 | 개시 | BTIG Research | Neutral |
| 2022-08-01 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-06-21 | 개시 | BofA Securities | Underperform |
모두보기
Embecta Corp 주식(EMBC)의 최신 뉴스
Embecta Corp. to Host Conference Call Discussing Q2 2026 Financial Results and Operational Update - Quiver Quantitative
embecta to Report Fiscal Second Quarter Financial Results - Yahoo Finance
Embecta Insider Ups Holding By 13% During Year - Sahm
Massachusetts Financial Services Co. MA Purchases 187,301 Shares of Embecta Corp. $EMBC - MarketBeat
Is Embecta (EMBC) One of the 10 Healthcare Stocks with Highest Dividends? - Insider Monkey
Embecta Corp. (NASDAQ: EMBC) Q1 2026 earnings call transcript - MSN
BTIG Maintains Embecta(EMBC.US) With Buy Rating, Cuts Target Price to $22 - Moomoo
(EMBC) and the Role of Price-Sensitive Allocations - Stock Traders Daily
How The Embecta (EMBC) Investment Story Is Shifting As Fair Value And Expectations Reset - Yahoo Finance
Embecta Corp stock (US29082K1051): Why does its diabetes focus matter more for U.S. investors now? - AD HOC NEWS
BTIG Reaffirms Their Buy Rating on Embecta Corporation (EMBC) - The Globe and Mail
Should You Investigate Embecta Corp. (NASDAQ:EMBC) At US$8.88? - Yahoo Finance
Embecta Corp stock: What investors need to know about its diabetes focus now - AD HOC NEWS
Embecta Corp. (EMBC) Stock Forecasts - Yahoo Finance
Aug Sectors: Why is Embecta Corp stock going up2026 Volume Leaders & Weekly Watchlist of Top Performers - baoquankhu1.vn
embecta Welcomes New Board Chair and Lead Independent Director - Medical Product Outsourcing
Responsive Playbooks and the EMBC Inflection - Stock Traders Daily
SG Americas Securities LLC Acquires Shares of 435,842 Embecta Corp. $EMBC - MarketBeat
EMBC SEC FilingsEmbecta Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Embecta Corp Stock: A Focused Leader in Diabetes Care with Proven Products and Strategic Independenc - AD HOC NEWS
Embecta Corp (JX7.MU) Stock Price, News, Quote & History - Yahoo! Finance Canada
JPMorgan Chase & Co. Boosts Stock Position in Embecta Corp. $EMBC - MarketBeat
Embecta Corp. (NASDAQ:EMBC) Sees Large Increase in Short Interest - MarketBeat
Embecta Corp. Stock Plummets to New 52-Week Low of $8.47 - Markets Mojo
Market Rankings: Why is Embecta Corp stock going upShort Setup & Risk Managed Investment Entry Signals - baoquankhu1.vn
Mills & Reeve advises Owen Mumford on £150m sale to embecta Corp in New Jersey - Business Weekly
Embecta agrees to acquire Owen Mumford - MSN
Embecta Corp. Stock Plummets to New 52-Week Low of $8.68 - Markets Mojo
Vanguard reorganizes reporting; EMBC ownership listed as 0 (EMBC) - Stock Titan
Embecta (NASDAQ:EMBC) Sets New 12-Month LowTime to Sell? - MarketBeat
Understanding the Setup: (EMBC) and Scalable Risk - Stock Traders Daily
“Landmark moment” for medical device manufacturer with sale to Nasdaq-listed groupMills & Reeve advised - Insider Media Ltd
Embecta Plans Acquisition of Owen Mumford to Broaden Drug-Delivery Offerings - Bitget
Embecta to Acquire Owen Mumford to Expand Drug-Delivery Portfolio - Zacks Investment Research
Embecta to buy Owen Mumford for up to £150M - MSN
Performance Recap: Will Embecta Corp stock go up in YEAR2026 Earnings & Daily Volume Surge Signals - baoquankhu1.vn
Embecta: £150 Million Acquisition Of Owen Mumford To Expand Drug Delivery Platform Capabilities - Pulse 2.0
Embecta rallies after UK firm deal worth $200 million - MSN
Aug Gainers: What is the PEG ratio of Embecta Corp2026 Big Picture & AI Forecasted Stock Moves - baoquankhu1.vn
Embecta to Acquire Owen Mumford for Up to £150 Million, Expanding Drug-Delivery Device Portfolio and Global Medical Supplies Presence 123 - Minichart
Embecta to Acquire Owen Mumford in £150M Deal, Expanding Drug Delivery and Chronic Care Portfolio - Pharmacy Times
Embecta to Acquire Owen Mumford, Expanding Drug-Delivery Portfolio - tipranks.com
Embecta (NASDAQ: EMBC) to acquire Owen Mumford in up to £150m deal - Stock Titan
Embecta to acquire Owen Mumford for up to £150 million By Investing.com - Investing.com India
Embecta Corp. agreed to acquire Owen Mumford Holdings Limited from Mark Owen, Adam Mumford, Ellen Owen, Kim Priddis,Nancy Millington and others for approximately £150 million. - MarketScreener
EmbectaAn Interesting Deal At An Interesting Time (NASDAQ:EMBC) - Seeking Alpha
Embecta to buy auto-injector maker Owen Mumford for $200M to diversify beyond insulin - Fierce Biotech
Embecta Corp (EMBC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.86%
1.85%
자본화:
|
볼륨(24시간):